Global Mesenchymal Stem Cells Market: Industry Analysis and Forecast (2021-2027) by Application, Product and Service, Type, Indication, Application, Source of Isolation, and Region

Global Mesenchymal Stem Cells Market size was valued at US$ 228.80 Mn. in 2019 and expected to reach US$ 490.45 Mn. by 2027 at a CAGR of 6% during the forecast period. Global Mesenchymal Stem Cells Market To know about the Research Methodology :- Request Free Sample Report The report has covered the market trends from 2015 to forecast the market through 2026. 2019 is considered a base year however 2020's numbers are on the real output of the companies in the market. Special attention is given to 2020 and the effect of lockdown on the demand and supply, and also the impact of lockdown for the next two years on the market. Some companies have done well in lockdown also and specific strategic analysis of those companies is done in the report.

Global Mesenchymal Stem Cells Market Overview:

Mesenchymal stem cells are strong adult stem cells that are existing in multiple soft tissues, like the umbilical cord, bone marrow, and fat tissue. Mesenchymal stem cells can be regenerated by dividing and can segregate into multiple tissues such as bone, cartilage, muscle and fat cells, and connective tissue. Moreover, Mesenchymal stem cells are also extracted from other tissues like cord blood, peripheral blood, fallopian tubes, and fetal lungs, and livers.

Global Mesenchymal Stem Cells Market Dynamics:

Rising the application of Mesenchymal stem cells in pre-clinical trials and the field of regenerative medicine is fueling the growth of the market in the forecast period. Continuous improvement in the field of stem cells therapies is a major factor for the growth of the market. Further, the launching of new gene therapies by the market players with operational strategies of mergers and acquisitions is boosting the market growth. In 2019, around 15 Mesenchymal stem cells products have received approval from regulatory agencies around the globe. Moreover, the companies are targeting the treatment of inflammatory disorders with Mesenchymal stem cells and this factor is likely to motivate market growth shortly. In addition, in 2020, around 60 clinical trials have been conducted on Mesenchymal stem cells for the development of treatment on the SARD-COV-2 virus. As the pandemic is growing due to the absence of vaccines and treatment and this factor has pushed the market players to carry out research activities. This factor has created more opportunities in the market for new entities to enter the existing market.

Global Mesenchymal Stem Cells Market Segment Analysis:

Allogeneic Segment is dominating the Mesenchymal Stem Cells Market:

The allogeneic segment accounts for the largest market share with a revenue share of 56.3% in 2020. The growth is proliferated by the utilization of highly safe allogeneic Mesenchymal stem cells in pre-clinical trials. As allogeneic Mesenchymal stem cells are responsible to suppress the immunological response as these cells are genetically dissimilar hence immunologically incompatible although from the same species of individuals. And this factor enhances the adoption of allogeneic Mesenchymal stem cells implantation. As per the EBMT survey 45,000, allogeneic transplants are carried out each year. And this factor is a key contribution towards the market growth.

Bone Marrow segment is considered to supplement the growth of the Mesenchymal Stem Cells Market:

The bone marrow segment is controlling the growth of the Mesenchymal stem cells market with a revenue share of 27.4% in 2020. As bone marrow is a major source of Mesenchymal stem cells. Mesenchymal stem cells have multilineage potentials and have the capacity to differentiate in tendons, cartilage, endothelial cells, fibroblast, fat, cardiac mussels and tissue, and bones. Further, bone marrow articulates from the pelvis and is a largely used source of Mesenchymal stem cells for clinical trials. This factor is likely to drive market growth in the forecast period. In addition, the bone marrow transplant market is estimated to grow with a CAGR of 3.7% during the forecast period and this factor is likely to stimulate the growth of the market in a positive direction. Adipose tissue is second dominating in the source segment of the Mesenchymal stem cells market with a growing CAGR of 12.7% during the forecast period.

The cardiovascular diseases segment is gaining more attention in the Mesenchymal Stem Cells Market:

The cardiovascular diseases segment is dominating in Mesenchymal stem cells market and accounted for 23.6% of the market share in 2019. The growth is attributed to the pre-clinical trials carried out on the transplantation of Mesenchymal stem cells that improves cardiac health. And this factor has boosted the penetration of Mesenchymal stem cells in the treatment of cardiovascular diseases. Moreover, the properties of Mesenchymal stem cells like reduce fibrosis, low inflammation, and improving myocardial cells with stimulating angiogenesis are likely to improve the market. Moreover, around 17.9 million people died due to cardiovascular diseases in 2019, and this represents 33% of global death of which 85% of deaths are due to heart attack and stroke. Further, 655,000 patients are suffering from heart disease in North America. Hence, Mesenchymal stem cells are gaining more attention in the cardiovascular disease segment and are proliferating the usage in the forecast period.

Diseases Modelling: New Trend of Source of Isolation in the Global Mesenchymal Stem Cells market:

The disease modeling segment has accounted for the largest market share of 37.4 % in 2020 and is likely to grow at a high pace in the forecast period. The application of the cellular disease model with the particular Mesenchymal stem cell is offering a perfect tool for pathology researchers. Moreover, the studies and researches carried out on chronic and life-threatening diseases is with the help of Mesenchymal stem cell modeling is likely to boost the market growth in the coming future. Further, the use of MSC to identify the non-hematological Mesenchymal cancers like sarcoma is the key factor contributing to the growth of the Mesenchymal stem cells market. Tissue engineering is simultaneously motivating the growth of the market at a rapid pace with 14.7% in the forecast period. As Mesenchymal stem cells have shown profiting therapeutics results in tissue engineering. Due to self-generation capacity, low occurrence of tumor and high capacity of expansion together with various other applications. These factors have gained a lot of attention and demand in the healthcare industry and are likely to sustain in the market. Global Mesenchymal Stem Cells Market

Global Mesenchymal Stem Cells Market Regional Insights:

North America dominates the Mesenchymal Stem Cells market owing to increasing development and technologies and account for the largest revenue share of 54.3% in 2020. The increasing demand for clinical trials and efficacy and safety of mesenchymal stem cells for chronic diseases in North America is fueling the market growth. Moreover, the companies are focusing on the commercialization of Mesenchymal stem cells and their supply to MSC headquarters. This key factor is further fueling the market growth of North America in the forecast period. Further, North America has strong research-based to estimate the implication of clinical scale production of Mesenchymal stem cells together with funding programs by various private organizations and these factors are stimulating the adoption of Mesenchymal stem cells around the globe. The Asia Pacific accounted for a reasonable share in the Mesenchymal Stem Cells market. Factors attributing to the growth of the region are increasing adoption of stem cell therapies owing to the low disposable income of individuals and stumpy financial support for high-end surgeries and this factor is likely to boost the application of Mesenchymal Stem Cells tools in the forecast period. Further, the low cost of Mesenchymal stem cell operation and increasing populations are anticipated to boost the approval of Mesenchymal stem cells in the Asia Pacific. China is leading in Asia Pacific regions as China is the biggest hub for cells and gene therapy and ranks second largest in clinical trials. China has marked more than 1000 clinical trials in 2019 and for phase I-486, Phase II-218, Phase III-304, and phase IV-24 clinical trials have been conducted in the year 2019. And this factor is likely to fuel the market growth of Asia Pacific in the forecast period. The objective of the report is to present a comprehensive analysis of the Global Mesenchymal Stem Cells Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding the Global Mesenchymal Stem Cells Market dynamics, structure by analyzing the market segments and project the Global Mesenchymal Stem Cells Market size. Clear representation of competitive analysis of key players by Type, price, financial position, Type portfolio, growth strategies, and regional presence in the Global Mesenchymal Stem Cells Market make the report investor’s guide.

Global Mesenchymal Stem Cells Market Scope: Inquire before buying

Global Mesenchymal Stem Cells Market, by Region

• North America o US o Canada o Mexico • Europe o U.K o France o Germany o Italy o Spain o Sweden o CIS Countries o Rest of Europe • Asia Pacific o China o India o Japan o South Korea o Australia o ASEAN o Rest of Asia Pacific • The Middle East and Africa o South Africa o GCC Countries o Egypt o Nigeria o Rest of ME&A • South America o Brazil o Argentina o Rest of South America

Global Mesenchymal Stem Cells Market Key Players

• Thermo Fisher Scientific, Inc. • Cell Applications, Inc. • Axol Biosciences Ltd. • Cytori Therapeutics Inc • STEMCELL Technologies Inc • Cyagen Biosciences Inc. • Celprogen Inc • BrainStorm Cell Therapeutics Inc. • Stemedica Cell Technologies Inc • Merck KGaA (MilliporeSigma) • Smith+Nephew • Lonza AG • PromoCell GmbH • ScienCell Research Laboratories • American Type Culture Collection

FAQs:

1. What is the global Mesenchymal Stem Cells market share in 2019? Ans: Approximately, 228.80 Million USD. 2. Which application segment is dominating the Mesenchymal Stem Cells market? Ans: Diseases modeling is the main application for Mesenchymal Stem Cells across the globe due to the rising research studies in the genomic sector and to innovative high-end diagnoses for chronic and life-threatening diseases like cancer. 3. Which Mesenchymal Stem Cells source is expected to dominate the market during the forecast period? Ans: The bone marrow segment is considered to dominate the market as the Source of Isolation segment. As bone marrow is a major source of Mesenchymal stem cells for pre-clinical trials. 4. Which region is expected to dominate the Mesenchymal Stem Cells market during the forecast period? Ans: North America dominates the Mesenchymal Stem Cells market owing to increasing development in viable treatment and the application of Mesenchymal stem cells in cancer treatment due to the high rate of cancer occurrence in the region. Moreover, increasing demand for better technologies with improved additions is the key factor considered to drive the growth of the Mesenchymal Stem Cells market. 5. What is the key driving factor for the growth of the Mesenchymal Stem Cells market? Ans: Rising application of Mesenchymal Stem Cells for SARS-CoV-2 infection is a key factor driving the growth of the market. As Mesenchymal stem cells have shown profiting application and result in boosting the antibody response.
1. Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Mesenchymal Stem Cells Market Size, by Market Value (US$ Mn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2019 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Mesenchymal Stem Cells Market, By Size 3.4. Geographical Snapshot of the Mesenchymal Stem Cells Market, By Manufacturer share 4. Global Mesenchymal Stem Cells Market Overview, 2019-2027 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Technological Trends and Emerging Technologies 4.1.6. Porter Five Forces Analysis 4.1.6.1. The threat of New Entrants 4.1.6.2. Bargaining Application of Buyers/Consumers 4.1.6.3. Bargaining Application of Suppliers 4.1.6.4. Threat of Substitute Technologies 4.1.6.5. Intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Global Mesenchymal Stem Cells Market 5. Supply Side and Demand Side Indicators 6. Global Mesenchymal Stem Cells Market Analysis and Forecast, 2019-2027 6.1. Global Mesenchymal Stem Cells Market Size & Y-o-Y Growth Analysis. 7. Global Mesenchymal Stem Cells Market Analysis and Forecasts, 2019-2027 7.1. Market Size (Value) Estimates & Forecast By Product and Service, 2019-2027 7.1.1. Products 7.1.1.1. Workflow Type 7.1.1.1.1. Cell Sourcing & Isolation 7.1.1.1.2. Culture & Cryopreservation 7.1.1.1.3. Differentiation 7.1.1.1.4. Characterization 7.1.1.2. Product Type 7.1.1.2.1. Cells & Cell Lines 7.1.1.2.2. Kits, Media, & Reagents 7.1.1.2.3. Others 7.1.2. Services 7.2. Market Size (Value) Estimates & Forecast By Application, 2019-2027 7.2.1. Disease Modelling 7.2.2. Drug Development & Discovery 7.2.3. Stem Cell Banking 7.2.4. Tissue Engineering 7.2.5. Toxicology Studies 7.2.6. Others 7.3. Market Size (Value) Estimates & Forecast By Type, 2019-2027 7.3.1. Autologous 7.3.2. Allogeneic 7.4. Market Size (Value) Estimates & Forecast By Indication, 2019-2027 7.4.1. Bone And Cartilage Repair 7.4.2. Cardiovascular Disease 7.4.3. Inflammatory And Immunological Diseases 7.4.4. Liver Diseases 7.4.5. Cancer 7.4.6. GvHD 7.4.7. Others 7.5. Market Size (Value) Estimates & Forecast By Source of Isolation, 2019-2027 7.5.1. Bone Marrow 7.5.2. Cord Blood 7.5.3. Peripheral Blood 7.5.4. Fallopian Tube 7.5.5. Fetal Liver 7.5.6. Lung 7.5.7. Adipose Tissue 8. Global Mesenchymal Stem Cells Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2019-2027 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America Mesenchymal Stem Cells Market Analysis and Forecasts, 2019-2027 9.1. Market Size (Value) Estimates & Forecast By Product and Service, 2019-2027 9.1.1. Products 9.1.1.1. Workflow Type 9.1.1.1.1. Cell Sourcing & Isolation 9.1.1.1.2. Culture & Cryopreservation 9.1.1.1.3. Differentiation 9.1.1.1.4. Characterization 9.1.1.2. Product Type 9.1.1.2.1. Cells & Cell Lines 9.1.1.2.2. Kits, Media, & Reagents 9.1.1.2.3. Others 9.1.2. Services 9.2. Market Size (Value) Estimates & Forecast By Application, 2019-2027 9.2.1. Disease Modelling 9.2.2. Drug Development & Discovery 9.2.3. Stem Cell Banking 9.2.4. Tissue Engineering 9.2.5. Toxicology Studies 9.2.6. Others 9.3. Market Size (Value) Estimates & Forecast By Type, 2019-2027 9.3.1. Autologous 9.3.2. Allogeneic 9.4. Market Size (Value) Estimates & Forecast By Indication, 2019-2027 9.4.1. Bone And Cartilage Repair 9.4.2. Cardiovascular Disease 9.4.3. Inflammatory And Immunological Diseases 9.4.4. Liver Diseases 9.4.5. Cancer 9.4.6. GvHD 9.4.7. Others 9.5. Market Size (Value) Estimates & Forecast By Source of Isolation, 2019-2027 9.5.1. Bone Marrow 9.5.2. Cord Blood 9.5.3. Peripheral Blood 9.5.4. Fallopian Tube 9.5.5. Fetal Liver 9.5.6. Lung 9.5.7. Adipose Tissue 10. North America Mesenchymal Stem Cells Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2019-2027 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Mesenchymal Stem Cells Market Analysis and Forecasts, 2019-2027 11.1. Market Size (Value) Estimates & Forecast By Product and Service, 2019-2027 11.2. Market Size (Value) Estimates & Forecast By Application, 2019-2027 11.3. Market Size (Value) Estimates & Forecast By Type, 2019-2027 11.4. Market Size (Value) Estimates & Forecast By Indication, 2019-2027 11.5. Market Size (Value) Estimates & Forecast By Source of Isolation, 2019-2027 12. Canada Mesenchymal Stem Cells Market Analysis and Forecasts, 2019-2027 12.1. Market Size (Value) Estimates & Forecast By Product and Service, 2019-2027 12.2. Market Size (Value) Estimates & Forecast By Application, 2019-2027 12.3. Market Size (Value) Estimates & Forecast By Type, 2019-2027 12.4. Market Size (Value) Estimates & Forecast By Indication, 2019-2027 12.5. Market Size (Value) Estimates & Forecast By Source of Isolation, 2019-2027 13. Mexico Mesenchymal Stem Cells Market Analysis and Forecasts, 2019-2027 13.1. Market Size (Value) Estimates & Forecast By Product and Service, 2019-2027 13.2. Market Size (Value) Estimates & Forecast By Application, 2019-2027 13.3. Market Size (Value) Estimates & Forecast By Type, 2019-2027 13.4. Market Size (Value) Estimates & Forecast By Indication, 2019-2027 13.5. Market Size (Value) Estimates & Forecast By Source of Isolation, 2019-2027 14. Europe Mesenchymal Stem Cells Market Analysis and Forecasts, 2019-2027 14.1. Market Size (Value) Estimates & Forecast By Product and Service, 2019-2027 14.2. Market Size (Value) Estimates & Forecast By Application, 2019-2027 14.3. Market Size (Value) Estimates & Forecast By Type, 2019-2027 14.4. Market Size (Value) Estimates & Forecast By Indication, 2019-2027 14.5. Market Size (Value) Estimates & Forecast By Source of Isolation, 2019-2027 15. Europe Mesenchymal Stem Cells Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2019-2027 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K. Mesenchymal Stem Cells Market Analysis and Forecasts, 2019-2027 16.1. Market Size (Value) Estimates & Forecast By Product and Service, 2019-2027 16.2. Market Size (Value) Estimates & Forecast By Application, 2019-2027 16.3. Market Size (Value) Estimates & Forecast By Type, 2019-2027 16.4. Market Size (Value) Estimates & Forecast By Indication, 2019-2027 16.5. Market Size (Value) Estimates & Forecast By Source of Isolation, 2019-2027 17. France Mesenchymal Stem Cells Market Analysis and Forecasts, 2019-2027 17.1. Market Size (Value) Estimates & Forecast By Product and Service, 2019-2027 17.2. Market Size (Value) Estimates & Forecast By Application, 2019-2027 17.3. Market Size (Value) Estimates & Forecast By Type, 2019-2027 17.4. Market Size (Value) Estimates & Forecast By Indication, 2019-2027 17.5. Market Size (Value) Estimates & Forecast By Source of Isolation, 2019-2027 18. Germany Mesenchymal Stem Cells Market Analysis and Forecasts, 2019-2027 18.1. Market Size (Value) Estimates & Forecast By Product and Service, 2019-2027 18.2. Market Size (Value) Estimates & Forecast By Application, 2019-2027 18.3. Market Size (Value) Estimates & Forecast By Type, 2019-2027 18.4. Market Size (Value) Estimates & Forecast By Indication, 2019-2027 18.5. Market Size (Value) Estimates & Forecast By Source of Isolation, 2019-2027 19. Italy Mesenchymal Stem Cells Market Analysis and Forecasts, 2019-2027 19.1. Market Size (Value) Estimates & Forecast By Product and Service, 2019-2027 19.2. Market Size (Value) Estimates & Forecast By Application, 2019-2027 19.3. Market Size (Value) Estimates & Forecast By Type, 2019-2027 19.4. Market Size (Value) Estimates & Forecast By Indication, 2019-2027 19.5. Market Size (Value) Estimates & Forecast By Source of Isolation, 2019-2027 20. Spain Mesenchymal Stem Cells Market Analysis and Forecasts, 2019-2027 20.1. Market Size (Value) Estimates & Forecast By Product and Service, 2019-2027 20.2. Market Size (Value) Estimates & Forecast By Application, 2019-2027 20.3. Market Size (Value) Estimates & Forecast By Type, 2019-2027 20.4. Market Size (Value) Estimates & Forecast By Indication, 2019-2027 20.5. Market Size (Value) Estimates & Forecast By Source of Isolation, 2019-2027 21. Sweden Mesenchymal Stem Cells Market Analysis and Forecasts, 2019-2027 21.1. Market Size (Value) Estimates & Forecast By Product and Service, 2019-2027 21.2. Market Size (Value) Estimates & Forecast By Application, 2019-2027 21.3. Market Size (Value) Estimates & Forecast By Type, 2019-2027 21.4. Market Size (Value) Estimates & Forecast By Indication, 2019-2027 21.5. Market Size (Value) Estimates & Forecast By Source of Isolation, 2019-2027 22. CIS Countries Mesenchymal Stem Cells Market Analysis and Forecasts, 2019-2027 22.1. Market Size (Value) Estimates & Forecast By Product and Service, 2019-2027 22.2. Market Size (Value) Estimates & Forecast By Application, 2019-2027 22.3. Market Size (Value) Estimates & Forecast By Type, 2019-2027 22.4. Market Size (Value) Estimates & Forecast By Indication, 2019-2027 22.5. Market Size (Value) Estimates & Forecast By Source of Isolation, 2019-2027 23. Rest of Europe Mesenchymal Stem Cells Market Analysis and Forecasts, 2019-2027 23.1. Market Size (Value) Estimates & Forecast By Product and Service, 2019-2027 23.2. Market Size (Value) Estimates & Forecast By Application, 2019-2027 23.3. Market Size (Value) Estimates & Forecast By Type, 2019-2027 23.4. Market Size (Value) Estimates & Forecast By Indication, 2019-2027 23.5. Market Size (Value) Estimates & Forecast By Source of Isolation, 2019-2027 24. Asia Pacific Mesenchymal Stem Cells Market Analysis and Forecasts, 2019-2027 24.1. Market Size (Value) Estimates & Forecast By Product and Service, 2019-2027 24.2. Market Size (Value) Estimates & Forecast By Application, 2019-2027 24.3. Market Size (Value) Estimates & Forecast By Type, 2019-2027 24.4. Market Size (Value) Estimates & Forecast By Indication, 2019-2027 24.5. Market Size (Value) Estimates & Forecast By Source of Isolation, 2019-2027 25. Asia Pacific Mesenchymal Stem Cells Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2019-2027 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Mesenchymal Stem Cells Market Analysis and Forecasts, 2019-2027 26.1. Market Size (Value) Estimates & Forecast By Product and Service, 2019-2027 26.2. Market Size (Value) Estimates & Forecast By Application, 2019-2027 26.3. Market Size (Value) Estimates & Forecast By Type, 2019-2027 26.4. Market Size (Value) Estimates & Forecast By Indication, 2019-2027 26.5. Market Size (Value) Estimates & Forecast By Source of Isolation, 2019-2027 27. India Mesenchymal Stem Cells Market Analysis and Forecasts, 2019-2027 27.1. Market Size (Value) Estimates & Forecast By Product and Service, 2019-2027 27.2. Market Size (Value) Estimates & Forecast By Application, 2019-2027 27.3. Market Size (Value) Estimates & Forecast By Type, 2019-2027 27.4. Market Size (Value) Estimates & Forecast By Indication, 2019-2027 27.5. Market Size (Value) Estimates & Forecast By Source of Isolation, 2019-2027 28. Japan Mesenchymal Stem Cells Market Analysis and Forecasts, 2019-2027 28.1. Market Size (Value) Estimates & Forecast By Product and Service, 2019-2027 28.2. Market Size (Value) Estimates & Forecast By Application, 2019-2027 28.3. Market Size (Value) Estimates & Forecast By Type, 2019-2027 28.4. Market Size (Value) Estimates & Forecast By Indication, 2019-2027 28.5. Market Size (Value) Estimates & Forecast By Source of Isolation, 2019-2027 29. South Korea Mesenchymal Stem Cells Market Analysis and Forecasts, 2019-2027 29.1. Market Size (Value) Estimates & Forecast By Product and Service, 2019-2027 29.2. Market Size (Value) Estimates & Forecast By Application, 2019-2027 29.3. Market Size (Value) Estimates & Forecast By Type, 2019-2027 29.4. Market Size (Value) Estimates & Forecast By Indication, 2019-2027 29.5. Market Size (Value) Estimates & Forecast By Source of Isolation, 2019-2027 30. Australia Mesenchymal Stem Cells Market Analysis and Forecasts, 2019-2027 30.1. Market Size (Value) Estimates & Forecast By Product and Service, 2019-2027 30.2. Market Size (Value) Estimates & Forecast By Application, 2019-2027 30.3. Market Size (Value) Estimates & Forecast By Type, 2019-2027 30.4. Market Size (Value) Estimates & Forecast By Indication, 2019-2027 30.5. Market Size (Value) Estimates & Forecast By Source of Isolation, 2019-2027 31. ASEAN Mesenchymal Stem Cells Market Analysis and Forecasts, 2019-2027 31.1. Market Size (Value) Estimates & Forecast By Product and Service, 2019-2027 31.2. Market Size (Value) Estimates & Forecast By Application, 2019-2027 31.3. Market Size (Value) Estimates & Forecast By Type, 2019-2027 31.4. Market Size (Value) Estimates & Forecast By Indication, 2019-2027 31.5. Market Size (Value) Estimates & Forecast By Source of Isolation, 2019-2027 32. Rest of Asia Pacific Mesenchymal Stem Cells Market Analysis and Forecasts, 2019-2027 32.1. Market Size (Value) Estimates & Forecast By Product and Service, 2019-2027 32.2. Market Size (Value) Estimates & Forecast By Application, 2019-2027 32.3. Market Size (Value) Estimates & Forecast By Type, 2019-2027 32.4. Market Size (Value) Estimates & Forecast By Indication, 2019-2027 32.5. Market Size (Value) Estimates & Forecast By Source of Isolation, 2019-2027 33. Middle East Africa Mesenchymal Stem Cells Market Analysis and Forecasts, 2019-2027 33.1. Market Size (Value) Estimates & Forecast By Product and Service, 2019-2027 33.2. Market Size (Value) Estimates & Forecast By Application, 2019-2027 33.3. Market Size (Value) Estimates & Forecast By Type, 2019-2027 33.4. Market Size (Value) Estimates & Forecast By Indication, 2019-2027 33.5. Market Size (Value) Estimates & Forecast By Source of Isolation, 2019-2027 34. Middle East Africa Mesenchymal Stem Cells Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2019-2027 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Mesenchymal Stem Cells Market Analysis and Forecasts, 2019-2027 35.1. Market Size (Value) Estimates & Forecast By Product and Service, 2019-2027 35.2. Market Size (Value) Estimates & Forecast By Application, 2019-2027 35.3. Market Size (Value) Estimates & Forecast By Type, 2019-2027 35.4. Market Size (Value) Estimates & Forecast By Indication, 2019-2027 35.5. Market Size (Value) Estimates & Forecast By Source of Isolation, 2019-2027 36. GCC Countries Mesenchymal Stem Cells Market Analysis and Forecasts, 2019-2027 36.1. Market Size (Value) Estimates & Forecast By Product and Service, 2019-2027 36.2. Market Size (Value) Estimates & Forecast By Application, 2019-2027 36.3. Market Size (Value) Estimates & Forecast By Type, 2019-2027 36.4. Market Size (Value) Estimates & Forecast By Indication, 2019-2027 36.5. Market Size (Value) Estimates & Forecast By Source of Isolation, 2019-2027 37. Egypt Mesenchymal Stem Cells Market Analysis and Forecasts, 2019-2027 37.1. Market Size (Value) Estimates & Forecast By Product and Service, 2019-2027 37.2. Market Size (Value) Estimates & Forecast By Application, 2019-2027 37.3. Market Size (Value) Estimates & Forecast By Type, 2019-2027 37.4. Market Size (Value) Estimates & Forecast By Indication, 2019-2027 37.5. Market Size (Value) Estimates & Forecast By Source of Isolation, 2019-2027 38. Nigeria Mesenchymal Stem Cells Market Analysis and Forecasts, 2019-2027 38.1. Market Size (Value) Estimates & Forecast By Product and Service, 2019-2027 38.2. Market Size (Value) Estimates & Forecast By Application, 2019-2027 38.3. Market Size (Value) Estimates & Forecast By Type, 2019-2027 38.4. Market Size (Value) Estimates & Forecast By Indication, 2019-2027 38.5. Market Size (Value) Estimates & Forecast By Source of Isolation, 2019-2027 39. Rest of ME&A Mesenchymal Stem Cells Market Analysis and Forecasts, 2019-2027 39.1. Market Size (Value) Estimates & Forecast By Product and Service, 2019-2027 39.2. Market Size (Value) Estimates & Forecast By Application, 2019-2027 39.3. Market Size (Value) Estimates & Forecast By Type, 2019-2027 39.4. Market Size (Value) Estimates & Forecast By Indication, 2019-2027 39.5. Market Size (Value) Estimates & Forecast By Source of Isolation, 2019-2027 40. South America Mesenchymal Stem Cells Market Analysis and Forecasts, 2019-2027 40.1. Market Size (Value) Estimates & Forecast By Product and Service, 2019-2027 40.2. Market Size (Value) Estimates & Forecast By Application, 2019-2027 40.3. Market Size (Value) Estimates & Forecast By Type, 2019-2027 40.4. Market Size (Value) Estimates & Forecast By Indication, 2019-2027 40.5. Market Size (Value) Estimates & Forecast By Source of Isolation, 2019-2027 41. South America Mesenchymal Stem Cells Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2019-2027 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Mesenchymal Stem Cells Market Analysis and Forecasts, 2019-2027 42.1. Market Size (Value) Estimates & Forecast By Product and Service, 2019-2027 42.2. Market Size (Value) Estimates & Forecast By Application, 2019-2027 42.3. Market Size (Value) Estimates & Forecast By Type, 2019-2027 42.4. Market Size (Value) Estimates & Forecast By Indication, 2019-2027 42.5. Market Size (Value) Estimates & Forecast By Source of Isolation, 2019-2027 43. Argentina Mesenchymal Stem Cells Market Analysis and Forecasts, 2019-2027 43.1. Market Size (Value) Estimates & Forecast By Product and Service, 2019-2027 43.2. Market Size (Value) Estimates & Forecast By Application, 2019-2027 43.3. Market Size (Value) Estimates & Forecast By Type, 2019-2027 43.4. Market Size (Value) Estimates & Forecast By Indication, 2019-2027 43.5. Market Size (Value) Estimates & Forecast By Source of Isolation, 2019-2027 44. Rest of South America Mesenchymal Stem Cells Market Analysis and Forecasts, 2019-2027 44.1. Market Size (Value) Estimates & Forecast By Product and Service, 2019-2027 44.2. Market Size (Value) Estimates & Forecast By Application, 2019-2027 44.3. Market Size (Value) Estimates & Forecast By Type, 2019-2027 44.4. Market Size (Value) Estimates & Forecast By Indication, 2019-2027 44.5. Market Size (Value) Estimates & Forecast By Source of Isolation, 2019-2027 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Global Mesenchymal Stem Cells Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, and R&D Investment 45.2.2. New Type Launches and Type Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment and Verticals 45.2.3.2. M&A, Forward Integration and Backward Integration 45.2.3.3. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements 45.3. Company Profile : Key Players 45.3.1. 10x Genomics 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Type Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Developments 45.3.2. Thermo Fisher Scientific, Inc. 45.3.3. Cell Applications, Inc. 45.3.4. Axol Biosciences Ltd. 45.3.5. Cytori Therapeutics Inc 45.3.6. STEMCELL Technologies Inc 45.3.7. Cyagen Biosciences Inc. 45.3.8. Celprogen Inc 45.3.9. BrainStorm Cell Therapeutics Inc. 45.3.10. Stemedica Cell Technologies Inc 45.3.11. Merck KGaA (MilliporeSigma) 45.3.12. Smith+Nephew 45.3.13. Lonza AG 45.3.14. PromoCell GmbH 45.3.15. ScienCell Research Laboratories 45.3.16. American Type Culture Collection 46. Primary Key Insights

About This Report

Report ID 114507
Category Healthcare
Published Date Jun 2021
Updated Date
Contact Us